VS Holdings, Inc. (the "Company"), the parent of Vitamin Shoppe Industries Inc., today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. Upon consummation of the offering, the Company will be renamed Vitamin Shoppe, Inc. The shares of common stock to be sold in the offering are expected to be offered by the Company.
J.P. Morgan, BofA Merrill Lynch and Barclays Capital will be the bookrunning managers of the offering. The number of shares to be offered and the price range of the offering have not yet been determined. The Company intends to apply to have its common stock listed on The New York Stock Exchange under the ticker symbol "VSI."
The Company expects to use the net proceeds of the offering to redeem a portion of Series A Preferred Stock it will have outstanding, to repurchase a portion of its Second Priority Senior Secured Floating Rate Notes, to make a payment related to the termination of its interest rate swap, for general corporate purposes, which may include the repayment of indebtedness and to pay related costs, fees and expenses.
A registration statement relating to a proposed initial public offering of common stock has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering of common stock will be made only by means of a prospectus. A copy of the preliminary prospectus, when available, may be obtained from:
J.P. Morgan, National Statement Processing, Prospectus Library, at 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245, or by telephone at (718) 242-8002; BofA Merrill Lynch at 4 World Financial Center, New York, NY 10080, Attention: Prospectus Department; and Barclays Capital Inc., c/o Broadridge Integrated Distribution Services, at 1155 Long Island Avenue, Edgewood, New York 11717, Toll Free (888) 603-5847, or by email at [email protected].
About Vitamin Shoppe Industries Inc.
Vitamin Shoppe is a leading specialty retailer and direct marketer of nutritional products based in North Bergen, New Jersey. The company sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beautyaids to customers located primarily in the United States. The company carries national brand products as well as exclusive products under Vitamin Shoppe, BodyTech, and MD Select proprietary brands.
Certain statements herein are "forward-looking statements" . Such forward-looking statements reflect the Company's current expectations or beliefs concerning future events and actual results of operations may differ materially from historical results or current expectations. Any such forward-looking statements are subject to various risks and uncertainties, including the strength of the economy, changes in the overall level of consumer spending, the performance of the Company's products within the prevailing retail environment, trade restrictions, availability of suitable store locations at appropriate terms and other factors which are set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 26, 2008 and in all filings with the Securities Exchange Commission made by the Company subsequent to the filing of the Form 10-K. The Company does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise.